Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin

2021 ◽  
Author(s):  
Marie C. Bradley ◽  
Yoganand Chillarige ◽  
Hana Lee ◽  
Xiyuan Wu ◽  
Shruti Parulekar ◽  
...  
Keyword(s):  
Severe Hypoglycemia ◽  
Insulin Analogs ◽  
Acting Insulin ◽  
Neutral Protamine Hagedorn ◽  
Long Acting

scholarly journals Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies

Diabetes Care ◽  
2016 ◽  
Vol 39 (3) ◽  
pp. 486-494 ◽  
Author(s):  
Jennifer W. Wu ◽  
Kristian B. Filion ◽  
Laurent Azoulay ◽  
Margaret K. Doll ◽  
Samy Suissa
Keyword(s):  
Systematic Review ◽  
Observational Studies ◽  
Insulin Analogs ◽  
Acting Insulin ◽  
Long Acting ◽  
Risk Of Cancer

Long-acting Insulin Analogs Effect on gh/igf Axis of Children with Type 1 Diabetes: a Randomized, Open-label, Two-period, Cross-over Trial

2016 ◽  
Vol 124 (05) ◽  
pp. 276-282 ◽  
Author(s):  
V. Cherubini ◽  
B. Pintaudi ◽  
A. Iannilli ◽  
M. Pambianchi ◽  
L. Ferrito ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Analogs ◽  
Open Label ◽  
Acting Insulin ◽  
Long Acting

A Case of Lipoatrophy With Insulin Glargine: Long-acting insulin analogs are not exempt from this complication

Diabetes Care ◽  
2005 ◽  
Vol 28 (12) ◽  
pp. 2983-2983 ◽  
Author(s):  
F. J. Ampudia-Blasco ◽  
J. Girbes ◽  
R. Carmena
Keyword(s):  
Insulin Glargine ◽  
Insulin Analogs ◽  
Acting Insulin ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document